| 证券代码：603579 | 证券简称：荣泰健康 | 公告编号：2023-027 | | --- | --- | --- | | 转债代码：113606 | 转债简称：荣泰转债 | | 上海荣泰健康科技股份有限公司 关于召开 2023 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2023 年 05 月 08 日（星期一）至 05 月 12 日（星期五）16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 Public@rotai.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 三、参加人员 总经理、董事：林琪先生 上海荣泰健康科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 28 日发布公司 2023 年第一季度报告，为便于广大投资者更全面深入地了解公司 2023 年第一季度经营成果、财务状况，公司计划于 2023 年 05 月 15 日上午 09:00- 10:00 举行 2023 年第一季度业绩说明会， ...

| 证券代码：603579 | 证券简称：荣泰健康 | 公告编号：2023-024 | | --- | --- | --- | | 转债代码：113606 | 转债简称：荣泰转债 | | 上海荣泰健康科技股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 04 月 18 日（星期二）下午 13:00-14:00 会议召开方式：上证路演中心网络文字互动 投资者可于 2023 年 04 月 11 日（星期二）至 04 月 17 日（星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 Public@rotai.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 上海荣泰健康科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 7 日 发布公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度 经营成果、财务状况，公司计划于 2023 年 04 月 18 ...

2022年年度报告 公司代码：603579 公司简称：荣泰健康 转债代码：113606 转债简称：荣泰转债 荣泰，更专业的按摩椅 上海荣泰健康科技股份有限公司 2022 年年度报告 ...

Financial Performance - The company's operating revenue for the first half of 2022 was RMB 1,101,358,555.51, a decrease of 11.78% compared to RMB 1,248,377,561.46 in the same period last year[21]. - The net profit attributable to shareholders for the first half of 2022 was RMB 86,367,502.94, down 38.47% from RMB 140,366,552.96 in the previous year[21]. - The net cash flow from operating activities decreased by 47.64%, amounting to RMB 98,446,913.62 compared to RMB 188,022,479.97 in the same period last year[21]. - Basic earnings per share for the first half of 2022 were RMB 0.65, a decline of 36.89% from RMB 1.03 in the same period last year[22]. - The weighted average return on equity decreased to 4.78%, down 3.48 percentage points from 8.26% in the previous year[22]. - The company reported a decrease of 28.37% in net profit after deducting non-recurring gains and losses, totaling RMB 79,921,203.93 compared to RMB 111,575,789.90 in the previous year[21]. - The company reported a significant increase in management expenses by 35.69% due to increased share-based payments compared to the previous year[65]. - The total comprehensive income for the first half of 2022 was CNY 85,488,588.12, a decrease of 38.4% from CNY 138,829,336.35 in the first half of 2021[144]. Assets and Liabilities - The total assets at the end of the reporting period were RMB 3,300,276,316.39, an increase of 0.68% from RMB 3,277,932,920.71 at the end of the previous year[21]. - The net assets attributable to shareholders at the end of the reporting period were RMB 1,774,162,416.72, a slight decrease of 0.12% from RMB 1,776,370,370.24 at the end of the previous year[21]. - Cash and cash equivalents at the end of the period reached ¥1,161,888,674.51, representing 35.21% of total assets, an increase of 4.75% year-over-year[68]. - Accounts receivable amounted to ¥147,652,941.81, accounting for 4.47% of total assets, with a year-over-year increase of 3.50%[68]. - Inventory decreased to ¥265,563,039.84, representing 8.05% of total assets, reflecting a decline of 5.01% compared to the previous year[68]. - Fixed assets totaled ¥495,386,136.35, making up 15.01% of total assets, down by 2.63% year-over-year[69]. - Short-term borrowings increased significantly to ¥228,805,644.52, which is 6.93% of total assets, marking a 99.36% increase from the previous year[69]. - The total liabilities as of June 30, 2022, were CNY 1,544,986,253.01, slightly down from CNY 1,551,197,088.41 at the beginning of the year[140]. Market and Industry Insights - The global market for massage equipment exceeded $15 billion in 2019, with China becoming the fastest-growing region for demand[28]. - The market size of China's massage appliance industry was 8.75 billion yuan in 2021, projected to reach 15.27 billion yuan by 2026[28]. - The massage equipment industry is expected to grow significantly due to increasing health awareness and the aging population in China[28]. - The company focuses on the design, R&D, production, and sales of massage equipment, aiming to provide a healthy lifestyle for global users[32]. - The company operates under a multi-channel sales model, including direct sales, e-commerce, and ODM for international markets[36]. - The company’s main products include full-function massage chairs and portable massage devices, catering to various user needs[32]. - The company emphasizes the integration of traditional Chinese medicine with modern technology in its product development[26]. Strategic Initiatives - The company aims to optimize internal management and strengthen product segmentation to adapt to market challenges and maintain its industry position[47]. - The company plans to focus on market expansion and new product development in the upcoming quarters[139]. - The company has initiated a strategic acquisition plan, targeting companies that align with its growth objectives, with a budget of 200,000 million for potential acquisitions[162]. - The company has actively expanded its online presence, particularly in the low-price segment, and has engaged in live-streaming sales to enhance brand visibility[53]. - The company launched new high-end products, including the M810 and M880 series, aimed at enhancing brand image and increasing market share in the premium segment[56]. Risks and Challenges - The company has outlined potential risks in its management discussion and analysis section, advising investors to be cautious[9]. - The company faces risks related to fluctuations in raw material prices, which could directly impact product costs and profitability[85]. - Increased competition in the massage equipment market has led to a focus on brand reputation and product functionality, with the company planning to enhance R&D investment to maintain technological leadership[89]. - The company primarily settles its export business in USD, exposing it to foreign exchange risks, which it aims to mitigate through various strategies including RMB settlement and hedging tools[88]. Corporate Governance and Compliance - The company has no significant litigation or arbitration matters during the reporting period[103]. - The company has fulfilled all commitments related to its initial public offering and refinancing[100]. - The company has maintained good integrity status, with no overdue debts or unfulfilled court judgments[103]. - The company has established a dedicated account for the management of the raised funds, in compliance with regulatory requirements[124]. - The company has confirmed that there are no significant doubts regarding its ability to continue as a going concern for the next 12 months[181].

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 1,101,358,555.51, a decrease of 11.78% compared to CNY 1,248,377,561.46 in the same period last year[21]. - The net profit attributable to shareholders for the first half of 2022 was CNY 86,367,502.94, down 38.47% from CNY 140,366,552.96 in the previous year[21]. - The net cash flow from operating activities decreased by 47.64% to CNY 98,446,913.62, compared to CNY 188,022,479.97 in the same period last year[21]. - Basic earnings per share for the first half of 2022 were CNY 0.65, a decline of 36.89% from CNY 1.03 in the previous year[22]. - The weighted average return on net assets decreased to 4.78%, down 3.48 percentage points from 8.26% in the same period last year[22]. - The company reported a decrease in net profit after deducting non-recurring gains and losses, which was CNY 79,921,203.93, down 28.37% from CNY 111,575,789.90 in the previous year[21]. - The company reported a significant increase in management expenses by 35.69% to approximately ¥45.73 million, attributed to increased share-based payments[65]. - The company reported a decrease in cash inflow from sales of goods and services, totaling ¥1,177,314,300.83, down 12.1% from ¥1,339,312,132.36 in the previous year[149]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,300,276,316.39, an increase of 0.68% from CNY 3,277,932,920.71 at the end of the previous year[21]. - The net assets attributable to shareholders at the end of the reporting period were CNY 1,774,162,416.72, a slight decrease of 0.12% from CNY 1,776,370,370.24 at the end of the previous year[21]. - Cash and cash equivalents at the end of the period reached ¥1,161,888,674.51, representing 35.21% of total assets, an increase of 4.75% year-over-year[68]. - Accounts receivable amounted to ¥147,652,941.81, accounting for 4.47% of total assets, with a year-over-year increase of 3.50%[68]. - Inventory decreased to ¥265,563,039.84, representing 8.05% of total assets, reflecting a decline of 5.01% compared to the previous year[68]. - Fixed assets totaled ¥495,386,136.35, making up 15.01% of total assets, down by 2.63% year-over-year[69]. - Short-term borrowings increased significantly to ¥228,805,644.52, which is 6.93% of total assets, marking a 99.36% increase from the previous year[69]. - The total liabilities of the company were reported at 3,776,100,000, indicating a slight increase from the previous year's 3,370,240,000[156]. Market and Industry Insights - The massage appliance industry has seen a global market size expansion, surpassing $10 billion in 2015 and $15 billion in 2019, with China's market expected to grow from 8.75 billion yuan in 2021 to 15.27 billion yuan by 2026[28]. - The company focuses on the design, research and development, production, and sales of massage appliances, aiming to provide a healthy lifestyle for global users[32]. - The company operates under a multi-channel sales model, including direct sales, e-commerce, and experience stores in the domestic market, while primarily using ODM for international markets[36]. - The company is positioned in a high-marketization industry, with significant export proportions and a focus on consumer health awareness[25]. - The massage appliance industry is expected to benefit from increasing health consciousness and the aging population, making it a promising market[30]. Strategic Initiatives - The company has a dual-brand strategy with "Rongtai" targeting the high-end market and "Momo Da" focusing on entry-level products, covering various consumer segments[49]. - The company has actively participated in the development of 17 industry standards, including 4 national standards, demonstrating its commitment to industry leadership[43]. - The company aims to strengthen its market position by focusing on innovation, technology, and cost reduction strategies amid external challenges[47]. - The company has launched multiple interactive initiatives with brand ambassador Wang Yibo to enhance brand engagement and drive sales[50]. - The company plans to focus on expanding its market presence and enhancing its product offerings in the upcoming quarters[159]. Research and Development - The company invested approximately ¥119 million in R&D, accounting for 4.56% of its total revenue, maintaining a consistent R&D investment ratio around 5% over the years[62]. - The company has allocated 44,459 million for research and development to enhance its technological capabilities[162]. - The company's research and development expenses for the first half of 2022 were CNY 45,671,497.44, down 21.6% from CNY 58,316,138.26 in the same period of 2021[142]. Risks and Challenges - The company faces risks related to fluctuations in raw material prices, which could directly impact product costs and profitability[85]. - The company is implementing domestic chip production and alternative parts strategies to mitigate risks associated with raw material price volatility[85]. - Increased competition in the massage equipment market has led to a focus on brand reputation and product functionality, with the company planning to enhance R&D investment to maintain technological leadership[89]. - The company primarily settles its export business in USD, exposing it to foreign exchange risks, which it aims to mitigate through various strategies including RMB settlement and hedging tools[88]. Shareholder and Equity Information - The total number of shares increased by 30,000, resulting in a total of 140,003,402 shares[114]. - The top three shareholders hold a combined total of 76.43% of the company's shares, with Lin Qi holding 28.93%, Lin Guangrong 18.36%, and Lin Jue 7.14%[120]. - The company has a total of 10,214 common stock shareholders as of the end of the reporting period[118]. - The company has established a dedicated account for the management of repurchased shares, holding 3,348,479 shares, which is 2.39% of the total shares[121]. Compliance and Governance - The company has no significant litigation or arbitration matters during the reporting period[103]. - The company has fulfilled all commitments related to its initial public offering and refinancing[100]. - The company has maintained good integrity status, with no unfulfilled court judgments or significant overdue debts[103]. - The financial statements are prepared based on the going concern assumption, with no significant doubts regarding the company's ability to continue operations for the next 12 months[181].

Financial Performance - The company's operating revenue for Q1 2022 was ¥564,797,326.35, representing an increase of 8.55% compared to the same period last year[5]. - The net profit attributable to shareholders decreased by 15.02% to ¥58,326,127.42[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 30.38% to ¥42,769,318.58, primarily due to a decline in gross margin[8]. - Net profit for Q1 2022 was ¥58,563,444.46, a decrease of 15.2% from ¥69,039,012.93 in Q1 2021[18]. - Total comprehensive income for Q1 2022 was CNY 58,341,010.73, a decrease from CNY 69,014,207.63 in Q1 2021[19]. - Basic earnings per share for Q1 2022 was CNY 0.44, down from CNY 0.50 in Q1 2021[19]. - The basic earnings per share for the period was ¥0.44, down by 12.00%[5]. - The diluted earnings per share was ¥0.42, a decrease of 12.50%[5]. - The weighted average return on equity was 3.23%, a decrease of 0.83 percentage points[5]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥27,415,890.24, a decrease of 146.53% compared to the previous year, mainly due to increased payments for purchased goods[8]. - Net cash flow from operating activities for Q1 2022 was negative CNY 27,415,890.24, compared to positive CNY 58,917,339.02 in Q1 2021[22]. - Cash inflow from operating activities totaled CNY 630,228,464.99 in Q1 2022, down from CNY 678,974,675.65 in Q1 2021[21]. - Cash outflow from operating activities increased to CNY 657,644,355.23 in Q1 2022, compared to CNY 620,057,336.63 in Q1 2021[22]. - Net cash flow from investing activities was CNY 70,058,635.23 in Q1 2022, a significant improvement from negative CNY 181,340,777.02 in Q1 2021[22]. - Cash inflow from financing activities was CNY 134,720,427.86 in Q1 2022, with net cash flow from financing activities of CNY 133,206,273.40[22]. - Cash and cash equivalents increased to ¥1,284,376,555.91 from ¥1,109,244,715.14 at the end of 2021, reflecting a growth of 15.8%[14]. - Cash and cash equivalents at the end of Q1 2022 were CNY 1,284,376,555.91, up from CNY 760,845,363.07 at the end of Q1 2021[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,370,609,904.10, an increase of 2.83% from the end of the previous year[6]. - The company's total assets as of March 31, 2022, amounted to ¥3,370,609,904.10, an increase from ¥3,277,932,920.71 at the end of 2021[14]. - Current assets totaled ¥2,131,739,325.31, slightly up from ¥2,038,261,461.70 at the end of 2021[14]. - Total liabilities increased to ¥1,528,376,484.16 from ¥1,497,786,372.69 at the end of 2021, marking a rise of 2.7%[15]. - The equity attributable to shareholders increased by 3.48% to ¥1,838,231,565.13[6]. - The equity attributable to shareholders rose to ¥1,838,231,565.13 from ¥1,776,370,370.24 at the end of 2021, an increase of 3.5%[15]. Shareholder Information - The company had a total of 9,277 common shareholders at the end of the reporting period[10]. Research and Development - The company reported a decrease in research and development expenses to ¥25,166,930.13 from ¥26,331,939.12 in Q1 2021, a decline of 4.4%[18]. Financial Expenses - The company’s financial expenses included interest expenses of ¥8,056,346.77, up from ¥7,034,346.26 in Q1 2021[18].

Financial Performance - Basic earnings per share for 2021 was CNY 1.75, an increase of 23.24% compared to CNY 1.42 in 2020[23] - Diluted earnings per share for 2021 was CNY 1.69, up 19.86% from CNY 1.41 in 2020[23] - The weighted average return on equity increased to 13.80% in 2021 from 12.09% in 2020, an increase of 1.71 percentage points[23] - The basic earnings per share after deducting non-recurring gains and losses was CNY 0.99, a decrease of 11.61% from CNY 1.12 in 2020[23] - The weighted average return on assets after deducting non-recurring gains and losses was 7.86%, down 1.83 percentage points from 9.69% in 2020[23] - In 2021, the company achieved operating revenue of RMB 2.613 billion, an increase of 29.30% compared to the previous year[29] - The net profit attributable to shareholders was RMB 236 million, up 22.45% year-on-year[29] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 12.92% to RMB 135 million[29] - The company's cash flow from operating activities was RMB 338 million, reflecting a 22.61% increase from the previous year[29] - By the end of 2021, the net assets attributable to shareholders reached RMB 1.776 billion, a growth of 7.05% year-on-year[29] - The total assets of the company increased to RMB 3.278 billion, marking an 11.11% rise compared to the previous year[29] Dividend and Shareholder Returns - The company plans to distribute a cash dividend of CNY 7.00 per 10 shares to all shareholders, based on the total share capital on the dividend distribution date[6] - The cash dividend policy includes a distribution of 7.00 yuan per 10 shares (before tax) for the year ending December 31, 2021[152] - The company has implemented a stable dividend policy and is committed to enhancing shareholder returns through continuous improvement of its dividend distribution policy[165] Market Expansion and Sales Performance - The company expanded its offline channels, achieving a national city coverage rate of 68%, with 100% coverage in first and second-tier cities[29] - The company launched a new store model in 2021, enhancing brand exposure and improving sales efficiency[29] - The "Momo Da" brand generated RMB 203 million in revenue, a year-on-year growth of 106.7%, selling 45,000 massage chairs[31] - The company collaborated with over 50 live-streaming influencers, significantly boosting online sales performance[30] - The company achieved an ODM business revenue of 1.392 billion CNY in 2021, representing a year-on-year growth of 31.94%[36] - The Korean market accounted for over 50% of the company's foreign trade business, with a year-on-year growth of 9.25%[36] - The company’s sales volume and revenue in the U.S. market doubled compared to 2020, with record-high sales figures[37] Research and Development - The company's R&D expenses totaled 119 million CNY, constituting 4.56% of total revenue, maintaining a consistent R&D expense ratio around 5%[38] - The company launched 12 completed R&D projects and has 15 ongoing projects, with 7 invention patents applied for and 2 new invention patents granted during the reporting period[38] - Research and development expenses increased by 19.06% to ¥119,207,415.61, indicating a commitment to innovation[71] - R&D expenses for the current period totaled ¥119,207,415.61, representing 4.56% of operating revenue[82] - The number of R&D personnel is 229, accounting for 17.7% of the total workforce[83] Production and Efficiency - The new factory project commenced operations in March 2021, enhancing production efficiency and automating production processes[40] - The company improved the efficiency of its Zhejiang factory's smart storage system by 30% after upgrades[41] - The company employs an order-based production model, ensuring efficient management of manufacturing processes[60] - The sales volume of massage chairs reached 346,176 units, an increase of 39.52% year-on-year, while the production volume was 303,381 units, reflecting a production increase of 24.26%[75] Risk Management and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[8] - The company has not violated decision-making procedures for external guarantees[8] - The company has provided a standard unqualified audit report from Zhonghui Certified Public Accountants[5] - The report includes a detailed description of potential risks faced by the company[10] - The company has not faced any penalties from securities regulatory agencies in the past three years[135] - The company has not identified any significant deficiencies in its internal control during the reporting period[162] Corporate Governance and Management - The company has engaged in multiple equity investments, including a 35% stake in BODYFRIEND, INC. for $3.5 million[90] - The company has a diverse board with members holding positions in various industries, enhancing strategic insights[132] - The company is focused on maintaining strong governance with regular board meetings to review key operational and financial matters[135] - The company has maintained a clear and complete decision-making process for cash dividends, ensuring the protection of minority shareholders' rights[156] Social Responsibility and Community Engagement - The company has actively participated in community service, achieving a satisfaction rate of over 98% in volunteer activities related to COVID-19 prevention[168] - The company has been recognized as an advanced unit for voluntary blood donation for eight consecutive years, reflecting its commitment to social responsibility[170] - The company has designed professional stores for distributors to enhance customer experience and support their business amid the challenges posed by the pandemic[170] Future Outlook and Strategic Goals - The company plans to expand its product range to include high, mid, and low-end massage chairs, enhancing competitiveness across various market segments, particularly with the introduction of ultra-high-end models featuring the latest technology[106] - Future strategic goals include acquiring companies in the health and wellness sector, particularly those with technological capabilities that can integrate with the company's massage products and cloud management systems[110] - The company is focusing on market expansion, targeting a 20% increase in market share over the next year[194] - Overall, the company is optimistic about achieving a net profit margin of 3.8% in the upcoming fiscal year[193]

Financial Performance - The company's operating revenue for Q3 2021 was ¥616,647,798.61, representing a year-on-year increase of 17.14%[5] - The net profit attributable to shareholders for the same period was ¥48,230,369.16, showing a decrease of 20.36% compared to the previous year[5] - The basic earnings per share for Q3 2021 was ¥0.36, down 18.18% year-on-year[6] - Total operating revenue for the first three quarters of 2021 reached ¥1,865,025,360.07, a significant increase from ¥1,405,243,697.89 in the same period of 2020, representing a growth of approximately 32.7%[19] - Net profit for the first three quarters of 2021 was ¥184,784,809.14, up from ¥150,533,424.81 in 2020, reflecting a growth of approximately 22.7%[20] - Earnings per share for the first three quarters of 2021 were ¥1.39, compared to ¥1.17 in the same period of 2020, marking an increase of 18.8%[21] - The total comprehensive income for the first three quarters of 2021 was ¥183,547,529.53, compared to ¥149,805,591.53 in 2020, reflecting an increase of approximately 22.6%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥3,071,148,483.00, reflecting a 4.10% increase from the end of the previous year[6] - The company’s equity attributable to shareholders increased by 3.38% to ¥1,715,500,457.44 compared to the previous year[6] - The total liabilities as of the end of the third quarter of 2021 amounted to ¥1,368,382,278.67, an increase from ¥1,299,988,643.69 at the end of 2020[20] - The company’s total assets as of the end of the third quarter of 2021 were ¥3,071,148,483.00, compared to ¥2,950,273,548.05 at the end of 2020[20] - Total liabilities included accounts payable of CNY 530,522,198.80 and contract liabilities of CNY 70,185,970.92[28] Cash Flow - The cash flow from operating activities for the year-to-date was ¥48,637,088.37, a decrease of 25.48%[6] - The company reported a total cash inflow from operating activities of ¥1,858,742,048.48 for the first three quarters of 2021, compared to ¥1,368,554,285.47 in the same period of 2020[23] - Operating cash inflow for Q3 2021 was CNY 2,001,270,555.83, an increase from CNY 1,507,770,747.49 in Q3 2020, representing a growth of approximately 32.7%[24] - The company reported a net cash flow from operating activities of CNY 48,637,088.37, down from CNY 65,264,870.16 in Q3 2020[24] Costs and Expenses - The company's operating costs increased by 43.05%, primarily due to rising raw material prices and adjustments in expense classifications[9] - Total operating costs for the first three quarters of 2021 were ¥1,678,950,250.44, compared to ¥1,242,435,966.80 in the previous year, indicating an increase of about 35.1%[20] - Research and development expenses for the first three quarters of 2021 were ¥88,671,626.60, up from ¥72,309,443.79 in 2020, indicating a growth of about 22.7%[20] Investments and Subsidies - The company reported a significant increase in investment income of 154.30% year-on-year, attributed to higher returns from financial investments[9] - The company received government subsidies amounting to ¥7,199,149.85 during the reporting period, which is an increase compared to the previous year[8] Stock and Equity - The company approved a restricted stock incentive plan during the board meetings held on August 26 and September 14, 2021, aimed at enhancing employee motivation and retention[14] - The total equity attributable to shareholders reached ¥1,715,500,457.44, compared to ¥1,659,416,997.40 in the previous year, showing an increase of approximately 3.4%[20] Current Assets and Inventory - The company's current assets totaled RMB 1,923,648,574.52, compared to RMB 1,816,811,642.31 at the end of 2020, indicating an increase of about 5.9%[16] - Accounts receivable increased by 83.25%, mainly due to the rise in operating revenue[9] - Inventory increased significantly to RMB 318,526,186.79, compared to no previous figure provided, indicating a strong focus on stock management[16] Cash and Equivalents - Cash and cash equivalents decreased to RMB 672,056,093.95 from RMB 882,664,744.58, reflecting a decline of approximately 23.8%[16] - Cash received from other operating activities was CNY 45,203,895.74, a decrease from CNY 63,226,543.93 in the previous year[24] Other Financial Metrics - The company incurred cash payments for employee compensation totaling CNY 179,157,879.18, compared to CNY 155,466,176.01 in Q3 2020[24] - The company experienced a negative impact of CNY -4,268,906.29 from foreign exchange fluctuations on cash and cash equivalents[25] Accounting Changes - The company adopted new leasing standards effective January 1, 2021, adjusting retained earnings and related financial statement items accordingly[30]

Financial Performance - Basic earnings per share for the first half of 2021 reached RMB 1.03, an increase of 41.10% compared to RMB 0.73 in the same period last year[21] - Diluted earnings per share for the first half of 2021 were RMB 1.00, reflecting a growth of 36.99% from RMB 0.73 in the previous year[21] - The weighted average return on net assets increased to 8.26%, up by 2.23 percentage points from 6.03% in the same period last year[21] - The weighted average return on net assets, excluding non-recurring gains and losses, was 6.56%, an increase of 1.36 percentage points from 5.20% in the previous year[21] - The basic earnings per share after deducting non-recurring gains and losses was RMB 0.82, a 30.16% increase from RMB 0.63 in the same period last year[21] - The company's operating revenue for the first half of the year reached ¥1,248,377,561.46, representing a 42.05% increase compared to ¥878,804,020.34 in the same period last year[22] - Net profit attributable to shareholders was ¥140,366,552.96, up 41.66% from ¥99,087,263.48 year-on-year[22] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥111,575,789.90, reflecting a 30.54% increase from ¥85,470,789.38 in the previous year[22] - The net cash flow from operating activities was ¥188,022,479.97, a significant recovery from a negative cash flow of -¥78,604,171.18 in the same period last year[22] Assets and Liabilities - As of the end of the reporting period, the net assets attributable to shareholders increased by 3.56% to ¥1,718,488,010.78 from ¥1,659,416,997.40 at the end of the previous year[22] - Total assets grew by 7.20% to ¥3,162,695,536.65 compared to ¥2,950,273,548.05 at the end of the previous year[22] - The company's cash and cash equivalents at the end of the reporting period amounted to ¥1,007,824,103.94, a 14.18% increase from ¥882,664,744.58 at the end of the previous year[60] - Inventory increased by 38.06% to ¥342,326,903.09, attributed to a rise in raw material stock[60] - Total liabilities were RMB 1,454,006,063.39, up from RMB 1,299,988,643.69, reflecting an increase of about 11.8%[134] Market and Industry - The company operates in the specialized equipment manufacturing industry, focusing on the design, research and development, production, and sales of massage devices[26] - The global market for massage devices is expected to reach approximately $18.4 billion by 2022, indicating significant growth potential[30] - The Chinese massage device market has rapidly expanded, with market size increasing from ¥10.6 billion in 2016 to ¥15 billion in 2020[31] Research and Development - R&D expenses for the first half of 2021 amounted to 58.32 million yuan, with 8 ongoing projects and multiple patents filed, including 7 invention patents[53] - Research and development expenses for the first half of 2021 were CNY 58,316,138.26, up from CNY 44,157,071.81 in the same period of 2020, representing an increase of about 31.9%[140] Corporate Governance and Compliance - The company reported no non-operating fund occupation by controlling shareholders and their related parties[7] - The company has not violated any decision-making procedures for providing guarantees to external parties[7] - The company has maintained good integrity status without any unfulfilled court judgments or significant overdue debts[96] - The company has disclosed its commitment to ensure the authenticity and completeness of its financial reports[94] Shareholder Information - The cash dividend distribution proposed is RMB 0.50 per share (including tax), with the record date set for June 23, 2021[105] - The largest shareholder, Lin Qi, holds 40,500,400 shares, representing 28.93% of the total shares[114] - The second-largest shareholder, Lin Guangrong, holds 25,700,000 shares, accounting for 18.36%[114] Risks and Challenges - The company faces risks from raw material price fluctuations, with over 80% of its cost structure dependent on raw materials[76] - The company is exposed to foreign exchange risks as its export business is primarily settled in USD, and it plans to manage this risk through various strategies[80] - The competition in the massage equipment market is intensifying, particularly in the high-end segment where brand reputation and functionality are critical[82] Future Plans and Investments - The company plans to enhance production efficiency and implement a domestic chip solution to mitigate risks[77] - The company plans to open 120 direct stores nationwide and establish a comprehensive after-sales service network as part of its fundraising investment projects[79] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[172] Financial Management - The company has committed to avoiding competition with peers and fulfilling other long-term commitments[93] - The total amount of related party transactions during the reporting period was RMB 3,558.12 million[97] - The company has not reported any significant environmental issues or penalties during the reporting period[91] Accounting and Reporting - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that its financial statements reflect a true and complete picture of its financial status and operating results[183] - The company prepares consolidated financial statements based on its own and subsidiaries' financial reports, reflecting the overall financial status, operating results, and cash flows of the entire corporate group[193]

Financial Performance - Operating revenue rose by 59.49% to CNY 520,319,585.55 year-on-year[6] - Net profit attributable to shareholders increased by 131.82% to CNY 68,631,874.93 compared to the same period last year[6] - Basic earnings per share reached CNY 0.50, up 127.27% from CNY 0.22 in the previous year[6] - The diluted earnings per share increased to CNY 0.48, up 118.18% from CNY 0.22[8] - Total operating revenue for Q1 2021 reached ¥520,319,585.55, a significant increase of 59.49% compared to ¥326,233,469.82 in the same period last year[15] - The net profit for Q1 2021 reached CNY 69.04 million, compared to CNY 27.64 million in Q1 2020, representing a 150.5% increase[28] - The total profit for Q1 2021 was CNY 73.96 million, significantly higher than CNY 31.66 million in Q1 2020, marking a 133.4% increase[28] - The company's operating profit for Q1 2021 was CNY 73.88 million, compared to CNY 32.03 million in Q1 2020, reflecting a 130.5% increase[28] Cash Flow - Net cash flow from operating activities was CNY 58,917,339.02, a significant recovery from a loss of CNY 227,682,868.54 in the previous year[6] - Cash flow from operating activities improved significantly to ¥58,917,339.02, compared to a negative cash flow of ¥-227,682,868.54 in the previous period[17] - The cash flow from operating activities for Q1 2021 was CNY 58.92 million, a turnaround from a negative cash flow of CNY -227.68 million in Q1 2020[33] - The company recorded a significant increase in cash inflow from operating activities, totaling CNY 678.97 million in Q1 2021, compared to CNY 373.75 million in Q1 2020[33] - The net cash flow from operating activities for Q1 2021 was ¥44,100,250.93, recovering from a loss of ¥269,878,263.94 in the same period last year[38] Assets and Liabilities - Total assets increased by 2.20% to CNY 3,015,302,869.58 compared to the end of the previous year[6] - Non-current assets increased by 4.13% to ¥1,180,274,203.81 from ¥1,133,461,905.74[20] - Total liabilities as of March 31, 2021, were ¥1,350,255,618.23, a slight decrease from ¥1,360,869,464.67 at the end of 2020[25] - Shareholders' equity increased to ¥1,690,646,544.27 from ¥1,653,242,406.63, reflecting a growth of 2.3%[25] Shareholder Information - The number of shareholders reached 9,321 by the end of the reporting period[10] - The top three shareholders held a combined 54.43% of the shares, with Lin Qi holding 28.93%[10][11] Expenses - Operating costs increased by 61.91% to ¥363,949,991.88 from ¥224,786,854.92, primarily due to higher sales and adjustments in operating expenses[15] - Sales expenses decreased by 16.35% to ¥37,178,661.28 from ¥44,447,106.90, attributed to the reclassification of operating expenses[16] - Research and development expenses for Q1 2021 were ¥26,331,939.12, compared to ¥22,436,820.50 in Q1 2020, marking an increase of 17.5%[26] Other Financial Metrics - The weighted average return on equity increased by 2.26 percentage points to 4.06%[6] - The company reported a total of CNY 7,196,923.89 in non-recurring gains and losses for the period[9] - The company experienced a significant increase in credit impairment losses, which rose by 360.30% to ¥-9,211,394.03 from ¥-2,001,185.82[16] - The company reported a decrease in financial expenses, with a net financial cost of -¥859,304.82, compared to -¥6,890,810.55 in the previous year[26]